ReviewCNS drugs2026

Next-Generation Pharmacotherapies for Unipolar Mood Disorders: A Leading Article on Phase II/III Drug Development Across Diverse Mechanisms.

Alana King et al.PubMed ↗Publisher ↗

No numbers read from the abstract.